CX3CL1 and Miyoshi myopathy: Clearly, the lack of relationship between CX3CL1 BM plasma levels and the presence of bone disease in MM patients excludes the possible role of this chemokine system in MM-induced osteoclastogenesis as reported for other pro-osteoclastogenic cytokines [38].